| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.982 | 0.002 | 0.983 | Hypolipemic | 0.921 0.003 DBMET02237 0.956 0.002 DBMET01698 0.983 0.002 DBMET01699 | DBMET01699 | |
| 0.982 | 0.002 | 0.982 | Vasodilator, coronary | 0.864 0.003 DBMET02237 0.718 0.004 DBMET01698 0.899 0.003 DBMET01699 | ||
| 0.913 | 0 | 0.922 | HMG CoA reductase inhibitor | 0.569 0.001 DBMET02237 0.76 0.001 DBMET01698 0.922 0 DBMET01699 | DBMET01699 | |
| 0.821 | 0 | 0.821 | Cholesterol synthesis inhibitor | 0.744 0.001 DBMET02237 0.759 0.001 DBMET01698 0.806 0 DBMET01699 | ||
| 0.824 | 0.011 | 0.844 | Transcription factor NF kappa B inhibitor | 0.763 0.015 DBMET02237 0.844 0.01 DBMET01698 0.723 0.018 DBMET01699 | DBMET01698 | |
| 0.74 | 0.004 | 0.74 | Apoptosis antagonist | 0.654 0.005 DBMET02237 0.671 0.005 DBMET01698 0.72 0.004 DBMET01699 | ||
| 0.716 | 0.005 | 0.716 | Immunosuppressant | 0.675 0.006 DBMET02237 0.585 0.015 DBMET01698 0.708 0.005 DBMET01699 | ||
| 0.7 | 0.003 | 0.718 | NOS3 expression enhancer | 0.527 0.005 DBMET02237 0.608 0.004 DBMET01698 0.718 0.003 DBMET01699 | DBMET01699 | |
| 0.66 | 0.012 | 0.739 | Antibacterial | 0.622 0.016 DBMET02237 0.739 0.006 DBMET01698 0.671 0.011 DBMET01699 | DBMET01698 | |
| 0.64 | 0.041 | 0.64 | Apoptosis agonist | 0.61 0.047 DBMET02237 0.577 0.054 DBMET01698 0.628 0.043 DBMET01699 | ||
| 0.603 | 0.005 | 0.603 | P-glycoprotein inhibitor | 0.448 0.012 DBMET02237 0.6 0.005 DBMET01698 0.568 0.005 DBMET01699 | ||
| 0.526 | 0.003 | 0.526 | ABCA1 expression enhancer | 0.393 0.004 DBMET02237 0.391 0.004 DBMET01698 0.495 0.004 DBMET01699 | ||
| 0.524 | 0.002 | 0.524 | Integrin alphaLbeta2 antagonist | 0.237 0.003 DBMET02237 0.276 0.002 DBMET01698 0.363 0.002 DBMET01699 | ||
| 0.479 | 0.001 | 0.479 | ICAM 1 antagonist | 0.102 0.003 DBMET02237 0.093 0.003 DBMET01698 0.141 0.002 DBMET01699 | ||
| 0.536 | 0.073 | 0.571 | Antiinflammatory | 0.523 0.078 DBMET02237 0.571 0.062 DBMET01698 0.507 0.084 DBMET01699 | DBMET01698 | |
| 0.403 | 0.008 | 0.501 | Protein kinase stimulant | 0.439 0.006 DBMET02237 0.501 0.004 DBMET01698 0.239 0.029 DBMET01699 | DBMET01698 | |
| 0.407 | 0.02 | 0.407 | Angiogenesis stimulant | 0.329 0.039 DBMET02237 0.385 0.024 DBMET01698 0.354 0.032 DBMET01699 | ||
| 0.41 | 0.033 | 0.434 | Antioxidant | 0.335 0.05 DBMET02237 0.422 0.031 DBMET01698 0.434 0.029 DBMET01699 | DBMET01699 | |
| 0.366 | 0.001 | 0.366 | Integrin beta2 antagonist | 0.081 0.003 DBMET02237 0.064 0.003 DBMET01698 0.092 0.002 DBMET01699 | ||
| 0.368 | 0.008 | 0.387 | Neurotrophic factor enhancer | 0.387 0.006 DBMET02237 0.311 0.015 DBMET01698 0.294 0.02 DBMET01699 | DBMET02237 | |
| 0.384 | 0.026 | 0.384 | Vasodilator | 0.296 0.049 DBMET02237 0.273 0.058 DBMET01698 0.374 0.028 DBMET01699 | ||
| 0.353 | 0.001 | 0.353 | LFA antagonist | 0.124 0.003 DBMET02237 0.126 0.003 DBMET01698 0.164 0.003 DBMET01699 | ||
| 0.365 | 0.017 | 0.374 | Hepatoprotectant | 0.335 0.021 DBMET02237 0.353 0.019 DBMET01698 0.374 0.016 DBMET01699 | DBMET01699 | |
| 0.37 | 0.034 | 0.37 | Platelet antagonist | 0.251 0.072 DBMET02237 0.324 0.045 DBMET01698 0.319 0.047 DBMET01699 | ||
| 0.361 | 0.03 | 0.425 | Nitric oxide antagonist | 0.401 0.025 DBMET02237 0.425 0.023 DBMET01698 0.352 0.031 DBMET01699 | DBMET01698 | |
| 0.382 | 0.054 | 0.481 | Cholesterol antagonist | 0.286 0.1 DBMET02237 0.296 0.094 DBMET01698 0.481 0.036 DBMET01699 | DBMET01699 | |
| 0.3 | 0.003 | 0.309 | Thioredoxin reductase inhibitor | 0.203 0.004 DBMET02237 0.226 0.004 DBMET01698 0.309 0.003 DBMET01699 | DBMET01699 | |
| 0.296 | 0.006 | 0.378 | ATPase inhibitor | 0.225 0.022 DBMET02237 0.234 0.018 DBMET01698 0.378 0.004 DBMET01699 | DBMET01699 | |
| 0.285 | 0.011 | 0.397 | Antineoplastic antibiotic | 0.229 0.017 DBMET02237 0.397 0.005 DBMET01698 0.281 0.011 DBMET01699 | DBMET01698 | |
| 0.317 | 0.062 | 0.317 | Interleukin 2 agonist | 0.299 0.074 DBMET02237 0.256 0.113 DBMET01698 0.306 0.069 DBMET01699 | ||
| 0.295 | 0.054 | 0.327 | Hypoglycemic | 0.218 0.097 DBMET02237 0.198 0.114 DBMET01698 0.327 0.044 DBMET01699 | DBMET01699 | |
| 0.247 | 0.009 | 0.257 | Microtubule formation inhibitor | 0.255 0.007 DBMET02237 0.257 0.007 DBMET01698 0.244 0.01 DBMET01699 | DBMET01698 | |
| 0.296 | 0.083 | 0.3 | Sodium/bile acid cotransporter inhibitor | 0.272 0.105 DBMET02237 0.3 0.079 DBMET01698 0.264 0.114 DBMET01699 | DBMET01698 | |
| 0.263 | 0.055 | 0.263 | Antimitotic | 0.256 0.058 DBMET02237 0.207 0.08 DBMET01698 0.222 0.072 DBMET01699 | ||
| 0.274 | 0.069 | 0.274 | DNA damaging | 0.208 0.109 DBMET01698 0.243 0.084 DBMET01699 | ||
| 0.282 | 0.084 | 0.373 | Immunostimulant | 0.262 0.091 DBMET02237 0.178 0.134 DBMET01698 0.373 0.058 DBMET01699 | DBMET01699 | |
| 0.226 | 0.029 | 0.268 | Interleukin 6 antagonist | 0.202 0.039 DBMET02237 0.17 0.064 DBMET01698 0.268 0.02 DBMET01699 | DBMET01699 | |
| 0.195 | 0.005 | 0.202 | Protein 50S ribosomal subunit inhibitor | 0.152 0.006 DBMET02237 0.202 0.005 DBMET01698 0.2 0.005 DBMET01699 | DBMET01698 | |
| 0.161 | 0.005 | 0.169 | ATPase (Vacuolar H+) inhibitor | 0.15 0.008 DBMET02237 0.15 0.008 DBMET01698 0.169 0.004 DBMET01699 | DBMET01699 | |
| 0.148 | 0.013 | 0.201 | Interleukin 12 antagonist | 0.136 0.018 DBMET02237 0.14 0.016 DBMET01698 0.201 0.005 DBMET01699 | DBMET01699 | |
| 0.22 | 0.095 | 0.303 | DNA synthesis inhibitor | 0.23 0.083 DBMET02237 0.303 0.043 DBMET01698 0.252 0.065 DBMET01699 | DBMET01698 | |
| 0.191 | 0.083 | 0.204 | Insulin sensitizer | 0.204 0.07 DBMET01698 0.2 0.074 DBMET01699 | DBMET01698 | |
| 0.2 | 0.099 | 0.25 | Peptidyltransferase inhibitor | 0.198 0.102 DBMET02237 0.25 0.05 DBMET01698 0.234 0.063 DBMET01699 | DBMET01698 | |
| 0.109 | 0.024 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.021 DBMET02237 0.108 0.025 DBMET01698 0.111 0.023 DBMET01699 | DBMET02237 | |
| 0.155 | 0.071 | 0.218 | Interferon gamma antagonist | 0.2 0.041 DBMET02237 0.145 0.085 DBMET01698 0.218 0.035 DBMET01699 | DBMET01699 | |
| 0.104 | 0.021 | 0.117 | T cell inhibitor | 0.113 0.017 DBMET02237 0.081 0.062 DBMET01698 0.117 0.015 DBMET01699 | DBMET01699 | |
| 0.094 | 0.012 | 0.099 | Nitric oxide donor | 0.074 0.029 DBMET02237 0.077 0.025 DBMET01698 0.099 0.009 DBMET01699 | DBMET01699 | |
| 0.114 | 0.037 | 0.114 | mTOR complex 1 inhibitor | 0.11 0.044 DBMET01699 | ||
| 0.075 | 0.004 | 0.075 | Tubulin agonist | 0.069 0.004 DBMET02237 0.071 0.004 DBMET01698 0.075 0.004 DBMET01699 | ||
| 0.087 | 0.018 | 0.087 | Acetyl-CoA transferase inhibitor | 0.05 0.041 DBMET01698 0.066 0.026 DBMET01699 | ||
| 0.112 | 0.048 | 0.133 | Anabolic | 0.129 0.031 DBMET02237 0.133 0.029 DBMET01698 0.128 0.033 DBMET01699 | DBMET01698 | |
| 0.07 | 0.006 | 0.073 | Microtubule stabilization | 0.069 0.007 DBMET02237 0.071 0.006 DBMET01698 0.073 0.005 DBMET01699 | DBMET01699 | |
| 0.094 | 0.031 | 0.094 | CDC25A inhibitor | 0.08 0.043 DBMET01698 0.071 0.056 DBMET01699 | ||
| 0.147 | 0.086 | 0.208 | Melanin inhibitor | 0.162 0.067 DBMET02237 0.208 0.038 DBMET01698 0.143 0.091 DBMET01699 | DBMET01698 | |
| 0.113 | 0.057 | 0.113 | Interleukin 2 antagonist | 0.106 0.074 DBMET02237 0.107 0.071 DBMET01699 | ||
| 0.072 | 0.019 | 0.072 | Prolactin release inhibitor | 0.07 0.022 DBMET02237 0.07 0.023 DBMET01699 | ||
| 0.112 | 0.059 | 0.112 | Electron transport complex I inhibitor | 0.109 0.064 DBMET02237 0.11 0.062 DBMET01698 0.104 0.074 DBMET01699 | ||
| 0.128 | 0.083 | 0.128 | Neurotrophic factor | 0.12 0.094 DBMET01698 | ||
| 0.05 | 0.008 | 0.071 | ATP citrate lysase inhibitor | 0.071 0.004 DBMET02237 0.04 0.013 DBMET01698 0.032 0.021 DBMET01699 | DBMET02237 | |
| 0.149 | 0.107 | 0.251 | Lipocortins synthesis antagonist | 0.135 0.13 DBMET02237 0.251 0.033 DBMET01698 0.145 0.113 DBMET01699 | DBMET01698 | |
| 0.055 | 0.026 | 0.055 | Integrin antagonist | |||
| 0.042 | 0.017 | 0.05 | Squalene synthetase inhibitor | 0.05 0.014 DBMET01698 0.031 0.023 DBMET01699 | DBMET01698 | |
| 0.029 | 0.004 | 0.029 | Antibiotic Macrolide-like | 0.024 0.005 DBMET02237 0.029 0.004 DBMET01698 0.028 0.005 DBMET01699 | ||
| 0.058 | 0.036 | 0.058 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.044 DBMET02237 | ||
| 0.093 | 0.072 | 0.096 | Protease inhibitor | 0.088 0.077 DBMET02237 0.096 0.069 DBMET01699 | DBMET01699 | |
| 0.04 | 0.02 | 0.045 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.045 0.015 DBMET01698 | DBMET01698 | |
| 0.057 | 0.042 | 0.062 | Lipocortins synthesis agonist | 0.055 0.05 DBMET02237 0.062 0.031 DBMET01698 0.061 0.033 DBMET01699 | DBMET01698 | |
| 0.025 | 0.016 | 0.032 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET02237 0.032 0.012 DBMET01698 0.025 0.016 DBMET01699 | DBMET01698 | |
| 0.091 | 0.084 | 0.098 | AMP-activated protein kinase stimulant | 0.098 0.073 DBMET01699 | DBMET01699 | |
| 0.029 | 0.022 | 0.039 | RNA-directed RNA polymerase stimulant | 0.026 0.024 DBMET02237 0.039 0.017 DBMET01698 0.026 0.023 DBMET01699 | DBMET01698 | |
| 0.011 | 0.008 | 0.011 | Calcineurin inhibitor | 0.01 0.009 DBMET01699 | ||
| 0.031 | 0.027 | 0.031 | Histone deacetylase 2 inhibitor | |||
| 0.129 | 0.127 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.149 0.046 DBMET01698 0.13 0.118 DBMET01699 | DBMET01698 | |
| 0.066 | 0.064 | 0.066 | Glycine receptor agonist | |||
| 0.014 | 0.015 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.007 DBMET01698 0.015 0.013 DBMET01699 | DBMET01698 | |
| 0.019 | 0.025 | 0.03 | Vitamin D receptor antagonist | 0.03 0.007 DBMET02237 0.022 0.015 DBMET01699 | DBMET02237 | |
| 0.024 | 0.033 | 0.037 | Prostaglandin D2 agonist | 0.037 0.014 DBMET01699 | DBMET01699 | |
| 0.083 | 0.092 | 0.165 | Expectorant | 0.098 0.071 DBMET02237 0.096 0.073 DBMET01698 0.165 0.03 DBMET01699 | DBMET01699 | |
| 0.029 | 0.042 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.025 DBMET01698 | DBMET01698 | |
| 0.016 | 0.034 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.017 DBMET01699 | DBMET01699 | |
| 0.183 | 0.201 | 0.352 | Antithrombotic | 0.352 0.064 DBMET01699 | DBMET01699 | |
| 0.085 | 0.103 | 0.103 | Mucolytic | 0.102 0.075 DBMET02237 0.1 0.078 DBMET01698 0.103 0.073 DBMET01699 | DBMET01699 | |
| 0.141 | 0.171 | 0.251 | Tumour necrosis factor alpha release inhibitor | 0.175 0.13 DBMET02237 0.251 0.074 DBMET01699 | DBMET01699 | |
| 0.235 | 0.272 | 0.337 | Caspase 9 stimulant | 0.262 0.238 DBMET02237 0.295 0.199 DBMET01698 0.337 0.157 DBMET01699 | DBMET01699 | |
| 0.118 | 0.155 | 0.277 | Interleukin antagonist | 0.277 0.053 DBMET01699 | DBMET01699 | |
| 0.016 | 0.057 | 0.044 | Prostaglandin agonist | 0.044 0.012 DBMET01699 | DBMET01699 | |
| 0.019 | 0.067 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET01699 | DBMET01699 | |
| 0.076 | 0.126 | 0.121 | Toll-Like receptor 4 antagonist | 0.121 0.042 DBMET01699 | DBMET01699 | |
| 0.111 | 0.163 | 0.137 | Anesthetic general | 0.137 0.128 DBMET01699 | DBMET01699 | |
| 0.209 | 0.264 | 0.291 | Cyclophilin D inhibitor | 0.291 0.171 DBMET01699 | DBMET01699 | |
| 0.008 | 0.065 | 0.03 | Prostaglandin EP2 agonist | 0.03 0.012 DBMET01699 | DBMET01699 | |
| 0.057 | 0.116 | 0.096 | Antineoplastic alkaloid | 0.074 0.073 DBMET02237 0.096 0.05 DBMET01698 | DBMET01698 | |
| 0.033 | 0.111 | 0.059 | Glucose-6-phosphate translocase inhibitor | 0.059 0.025 DBMET01698 | DBMET01698 | |
| 0.031 | 0.125 | 0.053 | Parathyroid hormone antagonist | 0.053 0.017 DBMET02237 | DBMET02237 | |
| 0.109 | 0.33 | 0.234 | Immunomodulator | 0.234 0.128 DBMET01699 | DBMET01699 | |
| 0.042 | 0.273 | 0.2 | Lipid peroxidase inhibitor | 0.2 0.042 DBMET01698 | DBMET01698 | |
| 0.007 | 0.257 | 0.072 | Glucocorticoid antagonist | 0.072 0.008 DBMET02237 | DBMET02237 | |
| 0.006 | 0.324 | 0.171 | Progesterone receptor B antagonist | 0.171 0.001 DBMET02237 | DBMET02237 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |